Does asymptomatic bacteriuria increase the risk of adverse events or modify the efficacy of intradetrusor onabotulinumtoxinA injections?-Reference-Cited by-同舟云学术

Does asymptomatic bacteriuria increase the risk of adverse events or modify the efficacy of intradetrusor onabotulinumtoxinA injections?

Published:2019-10-02 Issue:1 Volume:39 Page:203-210
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Aharony Shachar¹,Przydacz Mikolaj¹²^ORCID,Van Ba Ornella L.¹^ORCID,Corcos Jacques¹

Affiliation:

1. Department of Urology, Jewish General Hospital McGill University Montreal Quebec Canada

2. Department of Urology Jagiellonian University Medical College Krakow Poland

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24169

Reference22 articles.

1. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

2. OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

3. CUA guideline on adult overactive bladder

4. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment

5. European Association of Urology (EAU). Non‐Oncology Guidelines; Neuro‐Urology 2018.https://uroweb.org/guideline/neuro‐urology/. Accessed October 2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of postinjection urinary tract infection on efficacy of intravesical onabotulinumtoxinA—A secondary analysis;Neurourology and Urodynamics;2023-04-22

2. The Utility of Urodynamic Studies in Neuro-Urological Patients;Biomedicines;2023-04-09

3. Intravesical botulinum toxin: Practice patterns from a survey of Canadian urologists;Canadian Urological Association Journal;2022-08-30

4. In vivo degradability and biocompatibility of a rheo-formed Mg-Zn-Sr alloy for ureteral implantation;J MAGNES ALLOY;2022

5. Behandlung rezidivierender Harnwegsinfekte bei PatientInnen mit neurogener Blasenfunktionsstörung;Journal für Urologie und Urogynäkologie/Österreich;2022-03-22